September 10, 2012 – The statement provides expanded indications for cardiac resynchronization therapy (CRT) in an effort to clarify which patients are most likely to benefit from CRT. Additional updates include guidance regarding the frequency of in-person and remote monitoring of patients with cardiovascular implantable electronic devices.
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay supersedes the pacemaker recommendations made in this 2012 Focused Update and 2008 guidelines.
Topic
- Clinical Topics
- Device Therapy
Resource Type
- Clinical Guidelines
Related Resources
 
			Clinical Guidelines
18F-FDG PET/CT and Radiolabeled Leukocyte SPECT/CT Imaging for the Evaluation of Cardiovascular Infection in the Multimodality Context
The American Society of Nuclear Cardiology (ASNC) and Heart Rhythm Society (HRS), in partnership with 9 other societies, have released a consensus statement on the…
		
		
		 
			March 11, 2024
 
			Clinical Guidelines
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation
The American College of Cardiology (ACC) and American Heart Association (AHA) released updated recommendations for preventing and managing atrial fibrillation. The new guideline was developed…
		
		
		 
			November 30, 2023
 
			Clinical Guidelines
2023 HRS/APHRS/LAHRS Guideline on Cardiac Physiologic Pacing for the Avoidance and Mitigation of Heart Failure
The Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Latin American Heart Rhythm Society (LAHRS) have partnered to provide guidance on cardiac…
		
		
		 
			May 20, 2023